Risk factors for bevacizumab-related proteinuria in patients with colorectal cancer and non-small cell lung cancer

Luo Xin, Ye Xiaofen, Cai Yingyun, Lyu Qianzhou

PDF(703 KB)
PDF(703 KB)
Adverse Drug Reactions Journal ›› 2019, Vol. 21 ›› Issue (2) : 118-122. DOI: 10.3760/cma.j.issn.1008-5734.2019.02.008

Risk factors for bevacizumab-related proteinuria in patients with colorectal cancer and non-small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 21(2): 118-122 https://doi.org/10.3760/cma.j.issn.1008-5734.2019.02.008

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(703 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉